Ford Financial Group LLC lowered its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 11.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 800 shares of the healthcare conglomerate’s stock after selling 99 shares during the period. Ford Financial Group LLC’s holdings in UnitedHealth Group were worth $249,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of UNH. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 7.5% during the second quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock worth $23,810,470,000 after buying an additional 5,654,194 shares during the period. Fisher Asset Management LLC lifted its holdings in UnitedHealth Group by 41,127.3% during the second quarter. Fisher Asset Management LLC now owns 2,347,070 shares of the healthcare conglomerate’s stock worth $692,268,000 after buying an additional 2,341,377 shares during the period. Nordea Investment Management AB lifted its holdings in UnitedHealth Group by 103.1% during the second quarter. Nordea Investment Management AB now owns 2,827,796 shares of the healthcare conglomerate’s stock worth $817,176,000 after buying an additional 1,435,755 shares during the period. GQG Partners LLC lifted its holdings in UnitedHealth Group by 50.0% during the second quarter. GQG Partners LLC now owns 2,105,870 shares of the healthcare conglomerate’s stock worth $621,353,000 after buying an additional 702,164 shares during the period. Finally, Two Sigma Advisers LP increased its position in shares of UnitedHealth Group by 195.8% during the second quarter. Two Sigma Advisers LP now owns 760,600 shares of the healthcare conglomerate’s stock worth $224,339,000 after purchasing an additional 503,500 shares in the last quarter. Institutional investors own 86.39% of the company’s stock.
Shares of UNH opened at $329.90 on Friday. The business’s 50-day moving average is $311.35 and its two-hundred day moving average is $297.69. The company has a market capitalization of $313.52 billion, a P/E ratio of 18.55, a P/E/G ratio of 1.44 and a beta of 0.68. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.84 and a current ratio of 0.84. UnitedHealth Group Inc has a fifty-two week low of $187.72 and a fifty-two week high of $333.70.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, topping the consensus estimate of $2.98 by $0.53. The company had revenue of $65.12 billion for the quarter, compared to the consensus estimate of $63.97 billion. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm earned $3.88 EPS. Analysts forecast that UnitedHealth Group Inc will post 16.58 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, September 11th. UnitedHealth Group’s dividend payout ratio is currently 33.09%.
In other news, EVP Marianne D. Short sold 12,000 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the sale, the executive vice president now directly owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $320.59, for a total transaction of $4,808,850.00. Following the sale, the director now directly owns 159,215 shares in the company, valued at $51,042,736.85. The disclosure for this sale can be found here. Insiders have sold a total of 47,336 shares of company stock worth $14,928,276 over the last ninety days. 0.80% of the stock is owned by insiders.
A number of equities analysts have recently issued reports on the company. Bank of America upped their price target on UnitedHealth Group from $351.00 to $365.00 and gave the stock a “buy” rating in a research report on Friday, August 28th. Piper Sandler upped their price target on UnitedHealth Group from $350.00 to $385.00 and gave the stock an “overweight” rating in a research report on Thursday. Morgan Stanley reaffirmed a “buy” rating and set a $371.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 16th. SVB Leerink upped their price target on UnitedHealth Group from $370.00 to $373.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Mizuho reaffirmed a “buy” rating and set a $315.00 price target on shares of UnitedHealth Group in a research report on Wednesday, July 15th. Four investment analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $346.68.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Insider Trading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.